Adventa Bioscience
Lodi, US · Founded 2020 · Delaware corporation
Founders & leadership
PL
Peter LambMr. Lamb is the COO if the Issuer
CT
Christopher TracyMr. Tracy is the CEO of the Issuer
WJ
William JacksonNamed on SEC filing
SW
Steven WynneNamed on SEC filing
JT
John Timothy ShortyNamed on SEC filing
CG
Chip GoodmanNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$410K disclosed across 1 round · 2022
▶$410KraisedMar 2022 · 2 investors · BiotechnologyRule 506(b)
▶$410KraisedMar 2022 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William JacksonDirector
- Steven WynneDirector
- John Timothy ShortyDirector
- Peter LambExecutive Officer
- Christopher TracyExecutive Officer
- Chip GoodmanDirector
- Offering amount
- $410K
- Amount sold
- $410K
- Minimum investment
- $5K
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b, 4a5
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Adventa Bioscience raised?
- Adventa Bioscience has disclosed $410K raised across 1 round.
- Where is Adventa Bioscience headquartered?
- Adventa Bioscience is headquartered in Lodi, US.